Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
   Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   M.J. Pittet et al., "Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients", INT IMMUNO, 1(7), 2001, pp. 1235-1247
2. Dan, QH; Sanchez, R; Delgado, C; Wepsic, HT; Morgan, K; Chen, YJ; Jeffes, EWB; Lowell, CA; Morgan, TR; Jadus, MR
   Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-Cell immunity against the parental tumor
   MOLECULAR THERAPY
   
   Q.H. Dan et al., "Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-Cell immunity against the parental tumor", MOL THER, 4(5), 2001, pp. 427-437
3. Nakano, K; Todo, T; Chijiiwa, K; Tanaka, M
   Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters
   MOLECULAR THERAPY
   
   K. Nakano et al., "Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters", MOL THER, 3(4), 2001, pp. 431-437
4. Williams, CC; Trinh, H; Tran, TV; Dan, QH; Sanchez, R; Delgado, C; Chen, YJ; Sippel, B; Jeffes, EWB; Wepsic, HT; Jadus, MR
   Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer
   MOLECULAR THERAPY
   
   C.C. Williams et al., "Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer", MOL THER, 3(2), 2001, pp. 216-224
5. Harada, M; Li, YF; El-Gamil, M; Ohnmacht, GA; Rosenberg, SA; Robbins, PF
   Melanoma-reactive CD8(+) T cells recognize a novel tumor antigen expressedin a wide variety of tumor types
   JOURNAL OF IMMUNOTHERAPY
   
   M. Harada et al., "Melanoma-reactive CD8(+) T cells recognize a novel tumor antigen expressedin a wide variety of tumor types", J IMMUNOTH, 24(4), 2001, pp. 323-333
6. Sun, H; Kundu, N; Dorsey, R; Jackson, MJ; Fulton, AM
   Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors
   JOURNAL OF IMMUNOTHERAPY
   
   H. Sun et al., "Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors", J IMMUNOTH, 24(2), 2001, pp. 138-143
7. Weiskirch, LM; Pan, ZK; Paterson, Y
   The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms
   CLINICAL IMMUNOLOGY
   
   L.M. Weiskirch et al., "The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms", CLIN IMMUNO, 98(3), 2001, pp. 346-357
8. Dobrzanski, MJ; Reome, JB; Dutton, RW
   Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection
   CLINICAL IMMUNOLOGY
   
   M.J. Dobrzanski et al., "Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection", CLIN IMMUNO, 98(1), 2001, pp. 70-84
9. Tanaka, Y; Koido, S; Chen, DS; Gendler, SJ; Kufe, D; Gong, JL
   Vaccination with allogeneic dendritic induces antitumor immunity in cells fused to carcinoma cells MUC1 transgenic mice
   CLINICAL IMMUNOLOGY
   
   Y. Tanaka et al., "Vaccination with allogeneic dendritic induces antitumor immunity in cells fused to carcinoma cells MUC1 transgenic mice", CLIN IMMUNO, 101(2), 2001, pp. 192-200
10. Berwin, B; Nicchitta, CV
    To find the road traveled to tumor immunity: The trafficking itineraries of molecular chaperones in antigen-presenting cells
    TRAFFIC
    
    B. Berwin e C.V. Nicchitta, "To find the road traveled to tumor immunity: The trafficking itineraries of molecular chaperones in antigen-presenting cells", TRAFFIC, 2(10), 2001, pp. 690-697
11. Sakaguchi, S; Takahashi, T; Yamazaki, S; Kuniyasu, Y; Itoh, M; Sakaguchi, N; Shimizu, J
    Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: Implications for autoimmunity and tumor immunity
    MICROBES AND INFECTION
    
    S. Sakaguchi et al., "Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: Implications for autoimmunity and tumor immunity", MICROBES IN, 3(11), 2001, pp. 911-918
12. Sicard, H; Al Saati, T; Delsol, G; Fournie, JJ
    Synthetic phosphoantigens enhance human V gamma 9V delta 2 T lymphocytes killing of non-Hodgkin's B lymphoma
    MOLECULAR MEDICINE
    
    H. Sicard et al., "Synthetic phosphoantigens enhance human V gamma 9V delta 2 T lymphocytes killing of non-Hodgkin's B lymphoma", MOL MED, 7(10), 2001, pp. 711-722
13. Rad, AN; Schlom, J; Hodge, JW
    Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    
    A.N. Rad et al., "Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors", CR R ONC H, 39(1-2), 2001, pp. 43-57
14. Gunzer, M; Grabbe, S
    Dendritic cells in cancer immunotherapy
    CRITICAL REVIEWS IN IMMUNOLOGY
    
    M. Gunzer e S. Grabbe, "Dendritic cells in cancer immunotherapy", CR R IMMUN, 21(1-3), 2001, pp. 133-145
15. Vonderheide, RH; Butler, MO; Liu, JF; Battle, TE; Hirano, N; Gribben, JG; Frank, DA; Schultze, JL; Nadler, LM
    CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    R.H. Vonderheide et al., "CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity", INT J ONCOL, 19(4), 2001, pp. 791-798
16. Akagi, J; Takai, E; Tamori, Y; Ogawa, M
    CD3(+)CD56(+)CD8(+) cells demonstrating a suppressor T cell-like function in the peripheral blood of colon cancer patients
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    J. Akagi et al., "CD3(+)CD56(+)CD8(+) cells demonstrating a suppressor T cell-like function in the peripheral blood of colon cancer patients", INT J ONCOL, 19(3), 2001, pp. 561-566
17. Thomas, R; Padmanabha, J; Chambers, M; McFadyen, S; Walpole, E; Nielssen, G; Smithers, M
    Metastatic lesions in the joint associated with acute inflammatory arthritis after dendritic cell immunotherapy for metastatic melanoma
    MELANOMA RESEARCH
    
    R. Thomas et al., "Metastatic lesions in the joint associated with acute inflammatory arthritis after dendritic cell immunotherapy for metastatic melanoma", MELANOMA RE, 11(2), 2001, pp. 167-173
18. Halliday, GM; Le, S
    Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin
    INTERNATIONAL IMMUNOLOGY
    
    G.M. Halliday e S. Le, "Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin", INT IMMUNOL, 13(9), 2001, pp. 1147-1154
19. Markiewicz, MA; Fallarino, F; Ashikari, A; Gajewski, TF
    Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A
    INTERNATIONAL IMMUNOLOGY
    
    M.A. Markiewicz et al., "Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A", INT IMMUNOL, 13(5), 2001, pp. 625-632
20. Smyth, MJ; Crowe, NY; Godfrey, DI
    NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
    INTERNATIONAL IMMUNOLOGY
    
    M.J. Smyth et al., "NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma", INT IMMUNOL, 13(4), 2001, pp. 459-463
21. Morikane, K; Tempero, RM; Sivinski, CL; Kitajima, S; Gendler, SJ; Hollingsworth, MA
    Influence of organ site and tumor cell type on MUC1-specific tumor immunity
    INTERNATIONAL IMMUNOLOGY
    
    K. Morikane et al., "Influence of organ site and tumor cell type on MUC1-specific tumor immunity", INT IMMUNOL, 13(2), 2001, pp. 233-240
22. Yano, T; Ishikura, H; Kato, H; Ogawa, Y; Kondo, S; Kato, H; Yoshiki, T
    Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: A model of tumor prevention and treatment in immune-compromised patients
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    T. Yano et al., "Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: A model of tumor prevention and treatment in immune-compromised patients", JPN J CANC, 92(1), 2001, pp. 83-87
23. Matsushita, R; Hattori, K; Hayashi, K; Iizasa, H; Ichimura, F; Nakashima, E
    Synergistic effect of indomethacin and bleomycin on tumor growth produced by activating antitumor immunity
    PHARMACEUTICAL RESEARCH
    
    R. Matsushita et al., "Synergistic effect of indomethacin and bleomycin on tumor growth produced by activating antitumor immunity", PHARM RES, 18(2), 2001, pp. 243-245
24. Takayanagi, T; Ohuchi, A
    A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes
    MICROBIOLOGY AND IMMUNOLOGY
    
    T. Takayanagi e A. Ohuchi, "A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes", MICROB IMMU, 45(10), 2001, pp. 709-715
25. Tao, GS; Hu, JY; Zou, HW; Lin, QH; Liu, FY; Wu, YL; Sun, QB
    Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene
    CHINESE MEDICAL JOURNAL
    
    G.S. Tao et al., "Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene", CHIN MED J, 114(6), 2001, pp. 623-627
26. Dietz, AB; Litzow, MR; Gastineau, DA; Vuk-Pavlovic, S
    Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia
    CROATIAN MEDICAL JOURNAL
    
    A.B. Dietz et al., "Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia", CROAT MED J, 42(4), 2001, pp. 428-435
27. Stater, LM; Stupecky, M; Sweet, P; Osann, K; Eklof, A; Arquilla, ER
    Etoposide induction of tumor immunity in Lewis lung cancer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    L.M. Stater et al., "Etoposide induction of tumor immunity in Lewis lung cancer", CANC CHEMOT, 48(4), 2001, pp. 327-332
28. Bergmann-Leitner, ES; Abrams, SI
    Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8(+) cytotoxic T lymphocytes
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    E.S. Bergmann-Leitner e S.I. Abrams, "Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8(+) cytotoxic T lymphocytes", CANCER IMMU, 50(9), 2001, pp. 445-455
29. Prins, RM; Graf, MR; Merchant, RE
    Cytotoxic T cells infiltrating a glioma express an aberrant phenotype thatis associated with decreased function and apoptosis
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    R.M. Prins et al., "Cytotoxic T cells infiltrating a glioma express an aberrant phenotype thatis associated with decreased function and apoptosis", CANCER IMMU, 50(6), 2001, pp. 285-292
30. Chong, SY; Zhang, M; Lin, YC; Coffman, F; Garcia, Z; Ponzio, N; Raveche, ES
    The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    S.Y. Chong et al., "The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells", CANCER IMMU, 50(1), 2001, pp. 41-50
31. Van Pel, A; De Plaen, E; Duffour, MT; Warnier, G; Uyttenhove, C; Perricaudet, M; Boon, T
    Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    A. Van Pel et al., "Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes", CANCER IMMU, 49(11), 2001, pp. 593-602
32. Ryan, MH; Abrams, SI
    Characterization of CD8(+) cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    M.H. Ryan e S.I. Abrams, "Characterization of CD8(+) cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant", CANCER IMMU, 49(11), 2001, pp. 603-612
33. Kim, KY; Kang, MA; Nam, MJ
    Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma
    CANCER LETTERS
    
    K.Y. Kim et al., "Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma", CANCER LETT, 166(1), 2001, pp. 33-40
34. Burgess, SC; Basaran, BH; Davison, TF
    Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype
    VETERINARY PATHOLOGY
    
    S.C. Burgess et al., "Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype", VET PATH, 38(2), 2001, pp. 129-142
35. Siemens, DR; Ratliff, TL
    Vaccines in urologic malignancies
    UROLOGICAL RESEARCH
    
    D.R. Siemens e T.L. Ratliff, "Vaccines in urologic malignancies", UROL RES, 29(3), 2001, pp. 152-162
36. Osborne, A; Zhang, HQ; Yang, WM; Seto, E; Blanck, G
    Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation
    MOLECULAR AND CELLULAR BIOLOGY
    
    A. Osborne et al., "Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation", MOL CELL B, 21(19), 2001, pp. 6495-6506
37. Hodge, JW; Grosenbach, DW; Rad, AN; Giuliano, M; Sabzevari, H; Schlom, J
    Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules
    VACCINE
    
    J.W. Hodge et al., "Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules", VACCINE, 19(25-26), 2001, pp. 3552-3567
38. Ohm, JE; Carbone, DP
    VEGF as a Mediator of tumor-associated immunodeficiency
    IMMUNOLOGIC RESEARCH
    
    J.E. Ohm e D.P. Carbone, "VEGF as a Mediator of tumor-associated immunodeficiency", IMMUNOL RES, 23(2-3), 2001, pp. 263-272
39. N'cho, M; Brahmi, Z
    Evidence that Fas-induced apoptosis leads to S phase arrest
    HUMAN IMMUNOLOGY
    
    M. N'cho e Z. Brahmi, "Evidence that Fas-induced apoptosis leads to S phase arrest", HUMAN IMMUN, 62(4), 2001, pp. 310-319
40. Wataya, H; Kamikawaji, N; Nakanishi, Y; Takayama, K; Hara, N; Sasazuki, T
    Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line
    HUMAN IMMUNOLOGY
    
    H. Wataya et al., "Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line", HUMAN IMMUN, 62(2), 2001, pp. 125-132
41. Schmitt, WE; Stassar, MJJG; Schmitt, W; Little, M; Cochlovius, B
    In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    W.E. Schmitt et al., "In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells", J CANC RES, 127(3), 2001, pp. 203-206
42. Badie, B; Schartner, J; Prabakaran, S; Paul, J; Vorpahl, J
    Expression of Fas ligand by microglia: possible role in glioma immune evasion
    JOURNAL OF NEUROIMMUNOLOGY
    
    B. Badie et al., "Expression of Fas ligand by microglia: possible role in glioma immune evasion", J NEUROIMM, 120(1-2), 2001, pp. 19-24
43. Musunuru, K; Darnell, RB
    Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration
    ANNUAL REVIEW OF NEUROSCIENCE
    
    K. Musunuru e R.B. Darnell, "Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration", ANN R NEUR, 24, 2001, pp. 239-262
44. Revaz, V; Benyacoub, J; Kast, WM; Schiller, JT; De Grandi, P; Nardelli-Haefliger, D
    Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice
    VIROLOGY
    
    V. Revaz et al., "Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice", VIROLOGY, 279(1), 2001, pp. 354-360
45. Hirahara, N; Nio, Y; Sasaki, S; Minari, Y; Takamura, M; Iguchi, C; Dong, M; Yamasawa, K; Tamura, K
    Inoculation of human interleukin-17 gene-transfected meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice
    ONCOLOGY
    
    N. Hirahara et al., "Inoculation of human interleukin-17 gene-transfected meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice", ONCOL-BASEL, 61(1), 2001, pp. 79-89
46. Hellstrom, I; Ledbetter, JA; Scholler, N; Yang, Y; Ye, ZM; Goodman, G; Pullman, J; Hayden-Ledbetter, M; Hellstrom, KE
    CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    I. Hellstrom et al., "CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer", P NAS US, 98(12), 2001, pp. 6783-6788
47. Nozawa, K; Ohata, J; Sakurai, J; Hashimoto, H; Miyajima, H; Yagita, H; Okumura, K; Azuma, M
    Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases
    JOURNAL OF IMMUNOLOGY
    
    K. Nozawa et al., "Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases", J IMMUNOL, 167(9), 2001, pp. 4981-4986
48. Fong, L; Brockstedt, D; Benike, C; Breen, JK; Strang, G; Ruegg, CL; Engleman, EG
    Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy
    JOURNAL OF IMMUNOLOGY
    
    L. Fong et al., "Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy", J IMMUNOL, 167(12), 2001, pp. 7150-7156
49. Siemens, DR; Elzey, BD; Lubaroff, DM; Bohlken, C; Jensen, RJ; Swanson, AK; Ratliff, TL
    Cutting edge: Restoration of the ability to generate CTL in mice immune toadenovirus by delivery of virus in a collagen-based matrix
    JOURNAL OF IMMUNOLOGY
    
    D.R. Siemens et al., "Cutting edge: Restoration of the ability to generate CTL in mice immune toadenovirus by delivery of virus in a collagen-based matrix", J IMMUNOL, 166(2), 2001, pp. 731-735
50. Helmich, BK; Dutton, RW
    The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: Factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors
    JOURNAL OF IMMUNOLOGY
    
    B.K. Helmich e R.W. Dutton, "The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: Factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors", J IMMUNOL, 166(11), 2001, pp. 6500-6508
51. Fonteneau, JF; Larsson, M; Somersan, S; Sanders, C; Munz, C; Kwok, WW; Bhardwaj, N; Jotereau, F
    Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells
    JOURNAL OF IMMUNOLOGICAL METHODS
    
    J.F. Fonteneau et al., "Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells", J IMMUNOL M, 258(1-2), 2001, pp. 111-126
52. Liu, XL; Bai, XF; Wen, J; Gao, JX; Liu, JQ; Lu, P; Wang, Y; Zheng, P; Liu, Y
    B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    X.L. Liu et al., "B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo", J EXP MED, 194(9), 2001, pp. 1339-1348
53. Tangri, S; Ishioka, GY; Huang, XQ; Sidney, J; Southwood, S; Fikes, S; Sette, A
    Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    S. Tangri et al., "Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide", J EXP MED, 194(6), 2001, pp. 833-846
54. Smyth, MJ; Cretney, E; Takeda, K; Wiltrout, RH; Sedger, LM; Kayagaki, N; Yagita, H; Okumura, K
    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    M.J. Smyth et al., "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis", J EXP MED, 193(6), 2001, pp. 661-670
55. Andersen, MH; Keikavoussi, P; Brocker, EB; Schuler-Thurner, B; Jonassen, M; Sondergaard, I; Straten, PT; Becker, JC; Kampgen, E
    Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression
    INTERNATIONAL JOURNAL OF CANCER
    
    M.H. Andersen et al., "Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression", INT J CANC, 94(6), 2001, pp. 820-824
56. Jurianz, K; Ziegler, S; Donin, N; Reiter, Y; Fishelson, Z; Kirschfink, M
    K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement
    INTERNATIONAL JOURNAL OF CANCER
    
    K. Jurianz et al., "K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement", INT J CANC, 93(6), 2001, pp. 848-854
57. Hoffmann, P; Mueller, N; Shively, JE; Fleischer, B; Neumaier, M
    Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity
    INTERNATIONAL JOURNAL OF CANCER
    
    P. Hoffmann et al., "Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity", INT J CANC, 92(5), 2001, pp. 725-732
58. van der Burg, SH; Ressing, ME; Kwappenberg, KMC; de Jong, A; Straathof, K; de Jong, J; Geluk, A; van Meugaarden, KE; Franken, KLMC; Ottenhoff, THM; Fleuren, GJ; Kenter, G; Melief, CJM; Offringa, R
    Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes
    INTERNATIONAL JOURNAL OF CANCER
    
    S.H. van der Burg et al., "Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes", INT J CANC, 91(5), 2001, pp. 612-618
59. Specht, C; Bexten, S; Kolsch, E; Pauels, HG
    Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression
    INTERNATIONAL JOURNAL OF CANCER
    
    C. Specht et al., "Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression", INT J CANC, 91(5), 2001, pp. 705-712
60. Johnsen, AK; France, J; Nagy, N; Askew, D; Abdul-Karim, FW; Gerson, SL; Sy, MS; Harding, CV
    Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence
    INTERNATIONAL JOURNAL OF CANCER
    
    A.K. Johnsen et al., "Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence", INT J CANC, 91(3), 2001, pp. 366-372
61. Jung, G; Brandl, M; Eisner, W; Fraunberger, P; Reifenbeger, G; Schlegel, U; Wiestler, OD; Reulen, FJ; Wilmanns, W
    Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situT-cell activation and therapeutic efficacy
    INTERNATIONAL JOURNAL OF CANCER
    
    G. Jung et al., "Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situT-cell activation and therapeutic efficacy", INT J CANC, 91(2), 2001, pp. 225-230
62. Salih, HR; Starling, GC; Knauff, M; Llewellyn, MB; Davis, PM; Pitts, WJ; Aruffo, A; Kiener, PA
    Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: Consequences for induction of apoptosis in CD95-sensitive cells
    EXPERIMENTAL CELL RESEARCH
    
    H.R. Salih et al., "Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: Consequences for induction of apoptosis in CD95-sensitive cells", EXP CELL RE, 270(2), 2001, pp. 248-258
63. Smola-Hess, S; Schnitzler, R; Hadaschik, D; Smola, H; Mauch, C; Krieg, T; Pfister, H
    CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: Imbalance between NF-kappa B and STAT3 activation
    EXPERIMENTAL CELL RESEARCH
    
    S. Smola-Hess et al., "CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: Imbalance between NF-kappa B and STAT3 activation", EXP CELL RE, 267(2), 2001, pp. 205-215
64. Ayyoub, M; Migliaccio, M; Guillaume, P; Lienard, D; Cerottini, JC; Romero, P; Levy, F; Speiser, DE; Valmori, D
    Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing.
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    M. Ayyoub et al., "Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing.", EUR J IMMUN, 31(9), 2001, pp. 2642-2651
65. Housseau, F; Moorthy, A; Langer, DA; Robbins, PF; Gonzales, MI; Topalian, SL
    N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    F. Housseau et al., "N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells", EUR J IMMUN, 31(9), 2001, pp. 2690-2701
66. Casares, N; Lasarte, JJ; de Cerio, ALD; Sarobe, P; Ruiz, M; Melero, I; Prieto, J; Borras-Cuesta, F
    Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    N. Casares et al., "Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity", EUR J IMMUN, 31(6), 2001, pp. 1780-1789
67. Chaux, P; Lethe, B; Van Snick, J; Corthals, J; Schultz, ES; Cambiaso, CL; Boon, T; van der Bruggen, P
    A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    P. Chaux et al., "A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells", EUR J IMMUN, 31(6), 2001, pp. 1910-1916
68. Tafuro, S; Meier, UC; Dunbar, PR; Jones, EY; Layton, GT; Hunter, MG; Bell, JI; McMichael, AJ
    Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta 2m fusion molecules
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    S. Tafuro et al., "Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta 2m fusion molecules", EUR J IMMUN, 31(2), 2001, pp. 440-449
69. Chiodoni, C; Stoppacciaro, A; Sangaletti, S; Gri, G; Cappetti, B; Koezuka, Y; Colombo, MP
    Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    C. Chiodoni et al., "Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases", EUR J IMMUN, 31(10), 2001, pp. 3101-3110
70. Guinn, BA; Bertram, EM; DeBenedette, MA; Berinstein, NL; Watts, TH
    4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors
    CELLULAR IMMUNOLOGY
    
    B.A. Guinn et al., "4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors", CELL IMMUN, 210(1), 2001, pp. 56-65
71. Bergmann-Leitner, ES; Abrams, SI
    Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions
    CELLULAR IMMUNOLOGY
    
    E.S. Bergmann-Leitner e S.I. Abrams, "Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions", CELL IMMUN, 209(1), 2001, pp. 49-62
72. Bishop, GA; Ramirez, LM; Baccam, M; Busch, LK; Pederson, LK; Tomai, MA
    The immune response modifier resiquimod mimics CD40-induced B cell activation
    CELLULAR IMMUNOLOGY
    
    G.A. Bishop et al., "The immune response modifier resiquimod mimics CD40-induced B cell activation", CELL IMMUN, 208(1), 2001, pp. 9-17
73. Shimizu, M; Fontana, A; Takeda, Y; Yoshimoto, T; Tsubura, A; Matsuzawa, A
    Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilicpolymorphonuclear leukocytes associated with antitumor immunity
    CELLULAR IMMUNOLOGY
    
    M. Shimizu et al., "Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilicpolymorphonuclear leukocytes associated with antitumor immunity", CELL IMMUN, 207(1), 2001, pp. 41-48
74. Strome, SE; Martin, B; Flies, D; Tamada, K; Chapoval, AI; Sargent, DJ; Shu, SY; Chen, LP
    Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic,major histocompatibility complex class I-negative A9P melanoma
    JOURNAL OF IMMUNOTHERAPY
    
    S.E. Strome et al., "Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic,major histocompatibility complex class I-negative A9P melanoma", J IMMUNOTH, 23(4), 2000, pp. 430-437
75. Sabel, MS; Conway, TF; Chen, FA; Bankert, RB
    Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice
    JOURNAL OF IMMUNOTHERAPY
    
    M.S. Sabel et al., "Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice", J IMMUNOTH, 23(3), 2000, pp. 362-368
76. Merad, M; Angevin, E; Wolfers, T; Flament, C; Lorenzi, I; Triebel, F; Escudier, B; Zitvogel, L
    Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)
    JOURNAL OF IMMUNOTHERAPY
    
    M. Merad et al., "Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)", J IMMUNOTH, 23(3), 2000, pp. 369-378
77. Ribas, A; Butterfield, LH; Hu, B; Dissette, VB; Chen, AY; Koh, A; Amarnani, SAN; Glaspy, JA; McBride, WH; Economou, JS
    Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells
    JOURNAL OF IMMUNOTHERAPY
    
    A. Ribas et al., "Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells", J IMMUNOTH, 23(1), 2000, pp. 59-66
78. Parker, G; Fernandes, H; Chong, SY; Czarneski, J; Ra, H; Lin, YC; Raveche, E
    Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells
    CYTOKINES CELLULAR & MOLECULAR THERAPY
    
    G. Parker et al., "Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells", CYTOK CELL, 6(3), 2000, pp. 113-119
79. Kuriyama, Y; Kawanishi, Y; Otawa, M; Utsumi, K; Ohyashiki, K
    Circulating and tumor-infiltrating gamma delta T cells in patients with B-cell lymphomas
    LEUKEMIA & LYMPHOMA
    
    Y. Kuriyama et al., "Circulating and tumor-infiltrating gamma delta T cells in patients with B-cell lymphomas", LEUK LYMPH, 39(3-4), 2000, pp. 321-327
80. Kuriyama, S; Mitoro, A; Tsujinoue, H; Toyokawa, Y; Nakatani, T; Yoshiji, H; Tsujimoto, T; Okuda, H; Nagao, S; Fukui, H
    Electrochemotherapy can eradicate established colorectal carcinoma and leaves a systemic protective memory in mice
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    S. Kuriyama et al., "Electrochemotherapy can eradicate established colorectal carcinoma and leaves a systemic protective memory in mice", INT J ONCOL, 16(5), 2000, pp. 979-985
81. Song, W; Tong, Y; Carpenter, H; Kong, HL; Crystal, RG
    Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen
    GENE THERAPY
    
    W. Song et al., "Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen", GENE THER, 7(24), 2000, pp. 2080-2086
82. Kim, YS; Sonn, CH; Paik, SG; Bothwell, ALM
    Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity
    GENE THERAPY
    
    Y.S. Kim et al., "Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity", GENE THER, 7(10), 2000, pp. 837-843
83. Marton, I; Johnson, SE; Damjanov, I; Currier, KS; Sundberg, JP; Knowles, BB
    Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas
    TRANSGENIC RESEARCH
    
    I. Marton et al., "Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas", TRANSGEN RE, 9(2), 2000, pp. 115-125
84. Yue, FY; Cao, L; Hemmi, S; Geertsen, R; Laine, E; Burg, G; Dummer, R
    Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?
    MELANOMA RESEARCH
    
    F.Y. Yue et al., "Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?", MELANOMA RE, 10(4), 2000, pp. 313-322
85. Kurt, RA; Park, JA; Schluter, SF; Marchalonis, JJ; Akporiaye, ET
    TCR V-beta usage and clonality of T cells isolated from progressing and rejected tumor sites before and after in vitro culture
    INTERNATIONAL IMMUNOLOGY
    
    R.A. Kurt et al., "TCR V-beta usage and clonality of T cells isolated from progressing and rejected tumor sites before and after in vitro culture", INT IMMUNOL, 12(5), 2000, pp. 639-646
86. Levy, DE; Gilliland, DG
    Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
    ONCOGENE
    
    D.E. Levy e D.G. Gilliland, "Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice", ONCOGENE, 19(21), 2000, pp. 2505-2510
87. Rakhmilevich, AL; Janssen, K; Hao, ZL; Sondel, PM; Yang, NS
    Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism
    CANCER GENE THERAPY
    
    A.L. Rakhmilevich et al., "Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism", CANC GENE T, 7(6), 2000, pp. 826-838
88. Termeer, CC; Schirrmacher, V; Brocker, EB; Becker, JC
    Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells
    CANCER GENE THERAPY
    
    C.C. Termeer et al., "Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells", CANC GENE T, 7(2), 2000, pp. 316-323
89. Jones, RK; Pope, IM; Kinsella, AR; Watson, AJM; Christmas, SE
    Combined suicide and granulocyte-macrophage colony-stimulating factor genetherapy induces complete tumor regression and generates antitumor immunity
    CANCER GENE THERAPY
    
    R.K. Jones et al., "Combined suicide and granulocyte-macrophage colony-stimulating factor genetherapy induces complete tumor regression and generates antitumor immunity", CANC GENE T, 7(12), 2000, pp. 1519-1528
90. Shibuya, TY; Wei, WZ; Zormeier, M; Ensley, J; Sakr, W; Mathog, RH; Meleca, RJ; Yoo, GH; June, CH; Levine, BL; Lum, LG
    Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    
    T.Y. Shibuya et al., "Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma", ARCH OTOLAR, 126(4), 2000, pp. 473-479
91. Weynants, P
    Immunity and lung cancer: perspectives for an antitumor vaccine
    REVUE DES MALADIES RESPIRATOIRES
    
    P. Weynants, "Immunity and lung cancer: perspectives for an antitumor vaccine", REV MAL RES, 17(1), 2000, pp. 371-380
92. Nielsen, MB; Marincola, FM
    Melanoma vaccines: the paradox of T cell activation without clinical response
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    M.B. Nielsen e F.M. Marincola, "Melanoma vaccines: the paradox of T cell activation without clinical response", CANC CHEMOT, 46, 2000, pp. S62-S66
93. Cerundolo, V
    Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    V. Cerundolo, "Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients", CANC CHEMOT, 46, 2000, pp. S83-S85
94. Moerch, U; Schrama, D; Guldberg, P; Seremet, T; Zeuthen, J; Becker, JC; Straten, PT
    Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    U. Moerch et al., "Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma", CANCER IMMU, 49(8), 2000, pp. 426-432
95. Kim, BG; Joo, HG; Chung, IS; Chung, HY; Woo, HJ; Yun, YS
    Inhibition of interieukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    B.G. Kim et al., "Inhibition of interieukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses", CANCER IMMU, 49(8), 2000, pp. 433-440
96. Rosales, C; Graham, VV; Rosas, GA; Merchant, H; Rosales, R
    A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    C. Rosales et al., "A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity", CANCER IMMU, 49(7), 2000, pp. 347-360
97. Bergmann-Leitner, ES; Abrams, SI
    Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8(+) cytotoxic T lymphocyte attack
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    E.S. Bergmann-Leitner e S.I. Abrams, "Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8(+) cytotoxic T lymphocyte attack", CANCER IMMU, 49(4-5), 2000, pp. 193-207
98. Ichii, S; Imai, Y; Irimura, T
    Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    S. Ichii et al., "Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins", CANCER IMMU, 49(1), 2000, pp. 1-9
99. Felzmann, T; Buchberger, M; Jechlinger, M; Kircheis, R; Wagner, E; Gadner, H
    Xenogenization by tetanus toroid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomes
    CANCER LETTERS
    
    T. Felzmann et al., "Xenogenization by tetanus toroid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomes", CANCER LETT, 161(2), 2000, pp. 241-250
100. Apostolopoulos, V; Barnes, N; Pietersz, GA; McKenzie, IFC
     Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses
     VACCINE
     
     V. Apostolopoulos et al., "Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses", VACCINE, 18(27), 2000, pp. 3174-3184